Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid STRIDE-CAP Training Vaccines 27.08.2026 Ecraid supports WHO Industry Dialogue on Global Antibiotic Development 19.08.2026 REMAP-CAP Finds Oseltamivir Ineffective in Critically Ill Influenza Patients Read the REMAP-CAP results from the recent preprint. 8.07.2026 Advancing ID & AMR Research Through Education: Connecting Knowledge, Expertise, and our Next Generation This month’s theme – Advancing ID & AMR Research Through Education – explores how connecting knowledge, expertise, and people ac… 7.07.2026 Now Online: Ecraid Annual Report 2025 For Ecraid, 2025 marked the transition towards a sustainable future 29.06.2026 The Experts and Partnerships Driving the Future of Infectious Disease Research Building Collaborations Across Borders. 22.06.2026 Response to Matters Arising about the Etiology of Ventilator-associated Pneumonia in the European POS-VAP Cohort Ecraid POS-VAP Study Group responds to scientific commentary in Critical Care. Load More
19.08.2026 REMAP-CAP Finds Oseltamivir Ineffective in Critically Ill Influenza Patients Read the REMAP-CAP results from the recent preprint.
8.07.2026 Advancing ID & AMR Research Through Education: Connecting Knowledge, Expertise, and our Next Generation This month’s theme – Advancing ID & AMR Research Through Education – explores how connecting knowledge, expertise, and people ac…
7.07.2026 Now Online: Ecraid Annual Report 2025 For Ecraid, 2025 marked the transition towards a sustainable future
29.06.2026 The Experts and Partnerships Driving the Future of Infectious Disease Research Building Collaborations Across Borders.
22.06.2026 Response to Matters Arising about the Etiology of Ventilator-associated Pneumonia in the European POS-VAP Cohort Ecraid POS-VAP Study Group responds to scientific commentary in Critical Care.
